Evotec, Harvard University in new kidney disease research alliance
The alliance also includes Brigham and Women’s Hospital. The deal will focus on kidney biology, physiology and disease along with a set of tools to identify, validate and
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.